Arnie,
Long-time follower of AMLN, so please forgive the lurker's cannonball into the pool.
First, congrats to all who have suffered long with this.
However,
<<As far as whole numbers, that would be astonishing for this disease>>
If you're referring to Type 2 diabetes, IMHO actually that is becoming the expectation. Metformin, 'glitazones and often sulfonylureas give exactly that type of response. In addition, views on insulin (which gives the quickest control) are shifting, and there are several studies under way to determine whether insulin truly has the side effects typically ascribed. There is already a product on the market which gives similar type improvements in HbA1c, Novo's repaglinide, and frankly sales have been disappointing.
On the positive side good weight gain is always a positive with diabetic agents. And a new agent in Type 1 is needed (some physicians try the Type 2 oral agents in their Type 1 patients b/c they feel such a need).
BTW, I am not short nor am I advocating anyone sell or sell short AMLN. Just thought I'd throw in my 1 1/2 cents worth. Let the partying resume.
biowa |
